Bramptons Medtronic of Canada has received Health Canada approval to develop a new technology that will help refractory epilepsy patients. The company has received a license for Medtronic Deep Brain Stimulation (DBS) Therapy. DBS therapy for refractory epilepsy delivers controlled electrical pulses to a location inside the brain involved in seizures. We are proud of the expansion of indications to include epilepsy, which will allow more patients to benefit from our DBS therapy, said Lothar Krinke, vice president and general manager of Medtronics neuromodulation division. The Health Canada license was granted as a result of data collected in during a clinical trial. The study evaluated the use of DBS therapy for patients with medically refractory epilepsy with partial-onset seizures. The trial collected data from 110 patients who were implanted with a Medtronic DBS system at 17 centers in the United States. To date, more than 85,000 patients worldwide have received Medtronic DBS therapy. Although not approved for refractory epilepsy in the U.S, it is approved in Europe. The therapy is currently licensed in Canada and approved in other regions including the European Union and the United States, for the treatment of the disabling symptoms of essential tremor, advanced Parkinsons disease and dystonia. The therapy is also approved for the treatment of severe, treatment-resistant obsessive-compulsive disorder not adequately controlled by medications in Europe and U.S. This Medtronic First innovation provides a viable option for patients who are not responsive to other therapies, Krinke added.
Brampton student equal to challenge
Brampton elementary school student Darren Dongs talent with numbers has added up to a stellar performance during this years World Maths Day competition.
Business looking to save every last drop
Spilling a few drops of fuel after filling up your car may seem like no big deal. But it happens often enough, and all that wasted gas adds up to millions of litres of fuel lost every year.
Here is the original post:
Medtronic to develop epilepsy treatment